| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2013 | US8481532 PDE-10 inhibitors |
| 07/09/2013 | US8481531 Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use |
| 07/09/2013 | US8481530 3β-hydroxysteroid dehydrogenase inhibitors |
| 07/09/2013 | US8481529 Combination cancer chemotherapy |
| 07/09/2013 | US8481528 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/09/2013 | US8481527 Benzamide derivatives as bradykinin antagonists |
| 07/09/2013 | US8481526 Fluoroquinolone carboxylic acid molecular crystals |
| 07/09/2013 | US8481525 Kinase inhibitors and method of treating cancer with same |
| 07/09/2013 | US8481523 Biocide composition comprising pyrithione and pyrrole derivatives |
| 07/09/2013 | US8481522 Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof |
| 07/09/2013 | US8481521 Methods of treating cell proliferative disorders |
| 07/09/2013 | US8481520 Compositions and methods for inhibiting cytochrome P450 |
| 07/09/2013 | US8481519 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy |
| 07/09/2013 | US8481518 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| 07/09/2013 | US8481517 Pyrrolidine compounds,pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the same |
| 07/09/2013 | US8481516 Ciclesonide containing sterile aqueous suspension |
| 07/09/2013 | US8481515 Derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
| 07/09/2013 | US8481514 Therapeutical uses of inecalcitol |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481512 Compositions and methods for modulation of vascular structure and/or function |
| 07/09/2013 | US8481511 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 07/09/2013 | US8481510 Uracyl spirooxetane nucleosides |
| 07/09/2013 | US8481503 Combination cancer therapy with an AKT inhibitor and other anticancer agents |
| 07/09/2013 | US8481502 Antibacterial aminoglycoside analogs |
| 07/09/2013 | US8481501 Synthesis of metabolically stable analgesics, pain medications and other agents |
| 07/09/2013 | US8481500 Compounds having neuroprotective properties |
| 07/09/2013 | US8481495 IAP inhibitors |
| 07/09/2013 | US8481494 Compounds for the treatment of diseases related to protein misfolding |
| 07/09/2013 | US8481279 Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | US8481088 Extract of Euodia suaveolens Scheff, repellent compositions and use thereof |
| 07/09/2013 | US8481083 Granular compositions of magnesium oxide and citric acid and uses thereof |
| 07/09/2013 | US8481079 Drug delivery system based on polyethylene vinylacetate copolymers |
| 07/09/2013 | US8481078 Solid dosage form comprising a fibrate |
| 07/09/2013 | US8481075 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 07/09/2013 | US8481069 Tyrosine kinase microspheres |
| 07/09/2013 | US8481067 Methods for promoting the revascularization and reenervation of CNS lesions |
| 07/09/2013 | US8481060 Melt-coated pharmaceutical composition with fast release |
| 07/09/2013 | US8481058 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 07/09/2013 | US8481055 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/09/2013 | US8481044 Neprilysin inhibitors |
| 07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 07/09/2013 | US8481025 Composition for maintaining healthy kidney function |
| 07/09/2013 | US8481019 Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof |
| 07/09/2013 | US8481017 Thin films for controlled protein interaction |
| 07/09/2013 | US8481015 Applying agmatine and a dermatologically acceptable carrier to the skin; inhibiting hair growth |
| 07/09/2013 | US8481009 Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| 07/09/2013 | US8481001 Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer |
| 07/09/2013 | DE202011110338U1 Zusammensetzung zum Lindern von Gelenkschmerzen unter Verwendung eines Gemischs aus Fischöl und einem von Fischöl stammenden, auf Cholin beruhenden, an Phospholipid gebunden Fettsäuregemisch beinhaltend mehrfach ungesättigte EPA und DHA A composition for alleviating joint pain using a mixture of fish oil and a fish oil-derived, based on choline, bound to phospholipid fatty acid mixture comprising highly unsaturated EPA and DHA |
| 07/09/2013 | CA2800260C Compositions and method for the treatment of multiple myeloma |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2735932C Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 07/09/2013 | CA2722087C 4-dimethylaminobutyric acid derivatives |
| 07/09/2013 | CA2682736C Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 07/09/2013 | CA2671749C Bicyclic compounds and uses as antidiabetics |
| 07/09/2013 | CA2640414C Combinations of botanical extracts for promoting cardiovascular health |
| 07/09/2013 | CA2640331C Stabilized pharmaceutical composition |
| 07/09/2013 | CA2629364C Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
| 07/09/2013 | CA2623237C Novel dosage formulation |
| 07/09/2013 | CA2609021C Compounds useful for treating neurodegenerative disorders |
| 07/09/2013 | CA2608726C Inhibitors of vegf receptor and hgf receptor signaling |
| 07/09/2013 | CA2606077C Polymorphic and amorphous salt forms of squalamine dilactate |
| 07/09/2013 | CA2598353C Non-fibrous transdermal therapeutic system and method for its production |
| 07/09/2013 | CA2597956C Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| 07/09/2013 | CA2580610C Diaminotriazole compounds useful as protein kinase inhibitors |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2567694C Novel galactoside inhibitors of galectins |
| 07/09/2013 | CA2567298C Methods and related compositions for reduction of fat |
| 07/09/2013 | CA2567268C Thienopyridinone compounds and methods of treatment |
| 07/09/2013 | CA2566931C Tablets exhibiting reduced drug release variability |
| 07/09/2013 | CA2566343C Nutritional composition for increasing creatine uptake in skeletal muscle |
| 07/09/2013 | CA2563739C Bioavailable solid dosage forms of metaxalone |
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 07/09/2013 | CA2556917C Process for preparing macrocyclic compounds |
| 07/09/2013 | CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 07/09/2013 | CA2520323C Tie-2 modulators and methods of use |
| 07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
| 07/09/2013 | CA2513242C Large-scale synthesis of selective androgen receptor modulators |
| 07/09/2013 | CA2463641C Antisense antiviral agent and method for treating ssrna viral infection |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2440249C Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354188C Cancer cell vaccine |
| 07/06/2013 | CA2771564A1 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| 07/05/2013 | DE202009018789U1 Polymer, das zur in vivo-Freisetzung bioaktiver Mittel angepasst ist, und pharmazeutische Zusammensetzung Polymer adapted for the in vivo release of bioactive agents, and pharmaceutical composition |
| 07/05/2013 | CA2800946A1 Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same |
| 07/04/2013 | WO2013102207A1 Estrogen receptor modulators for reducing body weight |
| 07/04/2013 | WO2013102203A1 MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT |
| 07/04/2013 | WO2013102195A1 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 07/04/2013 | WO2013102145A1 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| 07/04/2013 | WO2013102144A2 Ph20 polypeptede variants, formulations and uses thereof |
| 07/04/2013 | WO2013102142A1 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| 07/04/2013 | WO2013102101A1 Aptamers and diagnostic methods for detecting the egf receptor |
| 07/04/2013 | WO2013102085A1 Adhesive structure with tissue piercing protrusions on its surface |
| 07/04/2013 | WO2013102059A1 Pyrazolo [3, 4-d] pyrimidine and pyrrolo [2, 3-d] pyrimidine compounds as kinase inhibitors |
| 07/04/2013 | WO2013102007A1 Process for the production of furfural |
| 07/04/2013 | WO2013101974A1 Compounds for treating spinal muscular atrophy |
| 07/04/2013 | WO2013101964A1 Methods for treatment of breast cancer nonresponsive to trastuzumab |
| 07/04/2013 | WO2013101954A1 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors |